Published in Ann Intern Med on January 01, 1987
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A (2000) 3.48
Biochemistry and genetics of Klebsiella pneumoniae mutant strains unable to fix N2. J Bacteriol (1975) 2.89
Fructose-induced insulin resistance and hypertension in rats. Hypertension (1987) 2.43
A stimulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain. Biochem J (1971) 2.26
Implementing clinical practice guidelines while taking account of changing evidence: ATHENA DSS, an easily modifiable decision-support system for managing hypertension in primary care. Proc AMIA Symp (2000) 2.12
Nucleotide sequence of the tms genes of the pTiA6NC octopine Ti plasmid: two gene products involved in plant tumorigenesis. Proc Natl Acad Sci U S A (1984) 2.01
Preeclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia. Am J Obstet Gynecol (1994) 1.76
Venodilation in Raynaud's disease. Lancet (1993) 1.54
Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest (1992) 1.49
Liver cirrhosis and circadian rhythm. Ann Intern Med (1996) 1.44
Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding. Life Sci (1979) 1.42
Increased urinary transforming growth factor-beta(1) excretion in children with posterior urethral valves. Urology (2000) 1.40
Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol Exp Ther (1986) 1.28
Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens (1989) 1.24
Alpha-adrenergic receptor subtypes. N Engl J Med (1980) 1.23
Agonist versus antagonist binding to alpha-adrenergic receptors. Proc Natl Acad Sci U S A (1980) 1.22
A role for insulin in the aetiology and course of hypertension? Lancet (1987) 1.21
Nucleotide sequence and transcript mapping of the tmr gene of the pTiA6NC octopine Ti-plasmid: a bacterial gene involved in plant tumorigenesis. J Mol Appl Genet (1984) 1.20
A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc Natl Acad Sci U S A (1993) 1.19
Computer simulation of energy metabolism in anoxic perfused rat heart. Am J Physiol (1977) 1.14
Inhibition of lipolysis by adenosine is potentiated with age. J Clin Invest (1984) 1.13
Heterogeneity of radioligand binding to alpha-adrenergic receptors. Analysis of guanine nucleotide regulation of agonist binding in relation to receptor subtypes. J Biol Chem (1980) 1.13
Prolonged hyporesponsiveness of vascular smooth muscle contraction after halothane anesthesia in rabbits. Anesth Analg (1985) 1.13
High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. J Am Soc Nephrol (1999) 1.11
Offline testing of the ATHENA Hypertension decision support system knowledge base to improve the accuracy of recommendations. AMIA Annu Symp Proc (2006) 1.10
Gluconeogenesis in rat liver cytosol. I. Computer analysis of experimental data. Comput Biomed Res (1971) 1.10
Differential regulation of the alpha 2-adrenergic receptor by Na+ and guanine nucleotides. Nature (1980) 1.09
A convenient computer program for fitting enzymatic rate laws to steady-state data. Comput Biomed Res (1979) 1.09
Conjugates of catecholamines. II. In vitro and in vivo pharmacological activity of N-alkyl-functionalized carboxylic acid congeners and amides related to isoproterenol. Mol Pharmacol (1983) 1.08
Pharmacological characterizations of adrenergic receptors in human adipocytes. J Clin Invest (1981) 1.06
Calculation of free-Mg2+ concentration in adenosine 5'-triphosphate containing solutions in vitro and in vivo. Biochemistry (1984) 1.04
Alpha-adrenergic receptors in liver membranes: delineation with subtype selective radioligands. Life Sci (1981) 1.03
Identifying barriers to hypertension guideline adherence using clinician feedback at the point of care. AMIA Annu Symp Proc (2006) 1.02
Cardiomyopathy in a rat model of pheochromocytoma. Morphological and functional alterations. Am J Cardiovasc Pathol (1988) 1.01
Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. Br J Clin Pharmacol (1999) 1.01
Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation. J Pharmacol Exp Ther (1986) 1.01
Stiff differential equations. Annu Rev Biophys Bioeng (1977) 1.01
Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. Am J Physiol Renal Physiol (2000) 1.01
Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clin Pharmacol Ther (2000) 1.00
Heat shock activates c-Src tyrosine kinases and phosphatidylinositol 3-kinase in NIH3T3 fibroblasts. J Biol Chem (1997) 1.00
Desensitization of beta-adrenergic receptors by pheochromocytoma. Endocrinology (1984) 1.00
alpha1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase. J Pharmacol Exp Ther (1999) 0.99
Absence of age-related changes in venous responsiveness to nitroglycerin in vivo in humans. Clin Pharmacol Ther (1987) 0.98
Patient safety in guideline-based decision support for hypertension management: ATHENA DSS. Proc AMIA Symp (2001) 0.97
A simulation study of the metabolism and compartmentation in brain of glutamate, aspartate, the Krebs cycle, and related metabolites. J Biol Chem (1966) 0.97
A computer program for analyzing enzyme kinetic data using graphical display and statistical analysis. Comput Biomed Res (1984) 0.97
Computer simulation studies of mammalian pyruvate kinase. J Biol Chem (1967) 0.97
Alpha-1 adrenergic receptors in the nonfailing and failing human heart. J Pharmacol Exp Ther (1988) 0.97
Stimulation of TGF-beta type II receptor by high glucose in mouse mesangial cells and in diabetic kidney. Am J Physiol Renal Physiol (2000) 0.96
A simulation study of brain compartments. II. Atom-by-atom simulation of the metabolism of specifically labeled glucose and acetate. Brain Res (1970) 0.96
Computer simulation of metabolism in palmitate-perfused rat heart. I. Palmitate oxidation. Ann Biomed Eng (1983) 0.96
Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest (1991) 0.95
Role of alpha 1 adrenoceptors in the turnover of phosphatidylinositol and of alpha 2 adrenoceptors in the regulation of cyclic AMP accumulation in hamster adipocytes. Life Sci (1980) 0.95
Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med (2000) 0.95
Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes. Diabetes (1988) 0.95
Computer simulation of metabolism in palmitate-perfused rat heart. II. Behavior of complete model. Ann Biomed Eng (1983) 0.94
Lowering of plasma glucose in diabetic rats by antilipolytic agents. Am J Physiol (1988) 0.94
Desensitization of alpha-1 adrenergic receptor-mediated vascular smooth muscle contraction. J Pharmacol Exp Ther (1985) 0.93
Hypertension as a disease of carbohydrate and lipoprotein metabolism. Am J Med (1989) 0.93
Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVA. J Pharmacol Exp Ther (1995) 0.93
Heterogeneity of Wilson's disease in Israel. Isr J Med Sci (1977) 0.93
A machine-independent language for the simulation of complex chemical and biochemical systems. Comput Biomed Res (1968) 0.93
Alpha1 adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells. Role in mitogenesis. J Biol Chem (1996) 0.93
Computer simulation of metabolism of glucose-perfused rat heart in a work-jump. Am J Physiol (1982) 0.92
Desensitization of beta-adrenergic stimulated adenylate cyclase in turkey erythrocytes. J Cyclic Nucleotide Res (1979) 0.92
Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action. J Cardiovasc Pharmacol (1992) 0.92
Radioligand binding studies of adrenergic receptors: new insights into molecular and physiological regulation. Annu Rev Pharmacol Toxicol (1980) 0.91
Interactions of agonists with platelet alpha 2-adrenergic receptors. Endocrinology (1982) 0.91
Computer simulation of metabolism in pyruvate-perfused rat heart. II. Krebs cycle. Am J Physiol (1979) 0.90
Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients. Ann Intern Med (1992) 0.90
Mechanism of bradykinin-induced venodilation in humans. J Cardiovasc Pharmacol (1993) 0.90
Preferential uncoupling by manganese of alpha adrenergic receptor mediated inhibition of adenylate cyclase in human platelets. Biochem Biophys Res Commun (1981) 0.90
Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy. J Clin Invest (1989) 0.90
Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of beta gamma subunits in transducing enhanced activity of the type VI isoform. Mol Pharmacol (1996) 0.90
Evidence for activation of the sympathetic nervous system by recombinant human interleukin-1 beta in humans. J Immunother Emphasis Tumor Immunol (1993) 0.90
Computer applications to biochemical kinetics. Annu Rev Biochem (1970) 0.89
Adrenergic receptors in the heart. Annu Rev Physiol (1982) 0.89
Pheochromocytoma: a clinical and experimental overview. Curr Probl Cancer (1985) 0.89
Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation. Am J Physiol (1998) 0.89
Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension (1988) 0.89
Computer simulation of metabolism in pyruvate-perfused rat heart. V. Physiological implications. Am J Physiol (1979) 0.89
cAMP regulates transcription of the alpha 2A adrenergic receptor gene in HT-29 cells. J Biol Chem (1991) 0.89
Effect of aging on beta 2-adrenergic receptor-stimulated flux of K+, PO4, FFA, and glycerol in human forearms. J Appl Physiol (1985) (1995) 0.88
Chloroquine-induced venodilation in human hand veins. Clin Pharmacol Ther (1997) 0.88
Effects of adrenergic receptor antagonists on cardiac morphological and functional alterations in rats harboring pheochromocytoma. J Pharmacol Exp Ther (1987) 0.88
Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats. Diabetes (1989) 0.88
Phosphoglyceric acid mutase. A computer simulation study. J Biol Chem (1969) 0.88
Histamine-induced venodilation in human beings involves both H1 and H2 receptor subtypes. J Allergy Clin Immunol (1994) 0.87
Responsiveness of superficial hand veins to alpha-adrenoceptor agonists in insulin-dependent diabetic patients. Clin Sci (Lond) (1992) 0.87
Angiotensin II induces transcription and expression of alpha 1-adrenergic receptors in vascular smooth muscle cells. Am J Physiol (1995) 0.87
Magnesium regulation of the glycolytic pathway and the enzymes involved. Magnesium (1985) 0.87
Pharmacokinetic and pharmacodynamic principles of drug therapy in old age. Part 1. Int J Clin Pharmacol Ther Toxicol (1989) 0.86
Computer simulation of ischemic rat heart purine metabolism. II. Model behavior. Am J Physiol (1977) 0.86
Impaired cAMP-mediated gene expression and decreased cAMP response element binding protein in senescent cells. Am J Physiol (1996) 0.86
A simulation study of brain compartments. I. Fuel sources, and GABA metabolism. Brain Res (1970) 0.86
Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers. Clin Pharmacol Ther (1999) 0.86
Kinetic analysis of monocarboxylate uptake into perfused rat hearts. J Mol Cell Cardiol (1985) 0.86
Activation of heat shock protein (hsp)70 and proto-oncogene expression by alpha1 adrenergic agonist in rat aorta with age. J Clin Invest (1996) 0.86
Identification of alpha 1 adrenergic receptors in rabbit aorta with [125I] BE2254. Life Sci (1984) 0.85
Insulin and insulin-like growth factor I differentially induce alpha1-adrenergic receptor subtype expression in rat vascular smooth muscle cells. J Clin Invest (1996) 0.85